Back to top
more

Veeva Systems (VEEV)

(Delayed Data from NYSE)

$204.67 USD

204.67
466,941

+0.14 (0.07%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $204.53 -0.14 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (68 out of 251)

Industry: Internet - Software

Better trading starts here.

Zacks News

Merit Medical (MMSI) to Acquire Cianna Medical, Shares Up

Merit Medical (MMSI) to leverage on Cianna Medical's SAVI and SCOUT platforms. The company plans to retain Cianna Medical's commercial and R&D teams after closure of the transaction.

    Tyler's Acquisition Spree Continues With MobileEyes Buyout

    Tyler Technologies (TYL) acquires MobileEyes to enhance its product portfolio with innovative technology solutions.

      Here's Why You Should Buy Inogen (INGN) Stock Right Now

      Inogen (INGN) is expected to gain from strong international foothold and a raised view for 2018.

        Baxter Collaborates With Mayo Clinic to Open Renal Care Center

        Per the agreement, Baxter (BAX) and Mayo Clinic researchers to form an outpatient clinic for kidney disease management, home dialysis and in-center dialysis services.

          Veeva's Technology Partner Joins Verix to Boost CRM Platform

          Veeva Systems' (VEEV) focus on cloud-based services is likely to favor the stock.

            AngioDynamics (ANGO) Q1 Earnings Miss, '19 Sales View Up

            AngioDynamics (ANGO) sees soft segmental performances in Q1; international sales surge.

              Tirthankar Chakraborty headshot

              New Strong Buy Stocks for September 28th

              Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday

                Cerner CommunityWorks Selected by Pershing Health System

                Cerner (CERN) witnesses consistent growth in the Electronic Health Record platform and Revenue Cycle Management solutions.

                  Baxter's (BAX) ALTAPORE Bioactive Bone Graft Gets FDA Nod

                  Baxter's (BAX) offers a broad spectrum of surgical products, including bone grafts and substitutes that see lucrative market prospects.

                    Accuray's CyberKnife Manages Prostate Cancer Effectively

                    Accuray's (ARAY) flagship CyberKnife is the only robotic radiotherapy system.

                      Here's Why You Should Buy Baxter International (BAX) Now

                      Baxter's (BAX) raised guidance for 2018 and a series of approvals make it a promising investment pick.

                        RTI Surgical's (RTIX) TETRAfuse Wins Spine Technology Award

                        RTI Surgical (RTIX) to receive the Spine Technology Award from Orthopedics This Week at the NASS 33rd Annual Meeting in Los Angeles.

                          Boston Scientific Thrives in Urology on New LithoVue Empower

                          Boston Scientific's (BSX) combination of LithoVue Empower and LithoVue Single-Use Digital Ureteroscope will put the whole stone manipulation procedure in the operating surgeon's hands.

                            Quest Diagnostics Grows in Fertility Services With New Buyout

                            Quest Diagnostics' (DGX) acquisition of ReproSource lies in tandem with the company's accelerated growth strategy, especially in advanced diagnostics.

                              Abiomed's Impella Ensures Higher Survival Rates, Shares Up

                              Abiomed's (ABMD) Impella successfully treats patients with cardiogenic shocks; market prospects bright.

                                Here's Why You Should Invest in PRA Health (PRAH) Stock Now

                                The CRO industry's bullish prospects currently make PRA Health (PRAH) a promising investment pick.

                                  TransEnterix's MST Medical Buyout to Boost Senhance Platform

                                  TransEnterix (TRXC) acquires Israel-based MST Medical, which will boost surgeons' effectiveness and make procedures quick and error-free.

                                    Veeva (VEEV) Up 16.1% Since Last Earnings Report: Can It Continue?

                                    Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                      Here's Why You Should Buy Intuitive Surgical (ISRG) Now

                                      Strength in the surgical platform and a string of developments make Intuitive Surgical (ISRG) a promising pick.

                                        Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now

                                        Becton, Dickinson (BD) is likely to gain from expansion into emerging overseas markets.

                                          Abbott Banks on New Approvals and Buyouts, Competition Rife

                                          Abbott's (ABT) receipt of FDA approval for XIENCE Sierra coronary stent system as well as a reimbursement approval in Japan for the same device will help it revive the dull Vascular business.

                                            Sreyoshi Mukherjee headshot

                                            3 Top Stocks From the Booming US Medical Products Industry

                                            The U.S. Medical Products industry is sturdy on solid focus on technological advancement.

                                              Cerner Integrated Platform Implemented by Spectrum Health

                                              Spectrum Health selects Cerner's (CERN) Cerner Integrated Platform to treat psychological disorders.

                                                Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now

                                                AngioDynamics (ANGO) to benefit from a solid product portfolio. However, the company???s core Peripheral Vascular business has been sluggish.

                                                  Veeva's Vault CDMS to Unify Clinical Data in Single Platform

                                                  Veeva's (VEEV) cloud-based applications' market prospects bright.